← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Montana Molecular, Llc
Bozeman, MT
$5,861,911
Total funding
9
Grants
Funding over time
peak $910.9K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,861,911 · 9
By mechanism
R44$4,458,769 · 4
R43$1,156,382 · 4
R41$246,760 · 1
Investigators at Montana Molecular, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
A robust assay for detecting agonist bias in living cells.$634,836
R44 · FY2019 · GM
A robust assay for detecting agonist bias in living cells.$600,181
R44 · FY2020 · GM
Fast and Accurate Tools for Measuring Fluorescence in Living Cells$585,457
R44 · FY2014 · NS
Fast and Accurate Tools for Measuring Fluorescence in Living Cells$582,394
R44 · FY2015 · NS
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder$482,109
R44 · FY2021 · DA
Fluorescent Biosensors for measuring the signaling kinetics of GPCR ligands that activate G12/13 pathways.$364,367
R43 · FY2025 · CA
Fast and Accurate Tools for Measuring Fluorescence in Living Cells$348,182
R43 · FY2011 · MH
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder$315,386
R44 · FY2022 · DA
Live Cell Fluorescent Assays for SARS-CoV-2 protease activity and COVID-19 Drug Discovery$300,000
R44 · FY2022 · AI
Live Cell Fluorescent Assays for SARS-CoV-2 protease activity and COVID-19 Drug Discovery$300,000
R44 · FY2023 · AI
Development of technologies to advance fast and accurate tools for measuring fluorescence in living cells, with emphasis on developing assays optimized for screening in neuronal cells and brain tissue$227,000
R44 · FY2017 · NS
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder$221,097
R44 · FY2019 · DA
Development of technologies to advance fast and accurate tools for measuring fluorescence in living cells, with emphasis on developing assays optimized for screening in neuronal cells and brain tissue$210,309
R44 · FY2018 · NS
Live Cell Assays to Identify and Interrogate Stressed Neurons in Models of Neurodegenerative Disease.$195,833
R43 · FY2018 · NS
A robust assay for detecting agonist bias in living cells.$193,000
R43 · FY2017 · GM
A New Modular Tool Set for Live Imaging and Manipulating the Nervous System$105,046
R41 · FY2009 · NS
A New Modular Tool Set for Live Imaging and Manipulating the Nervous System$105,046
R41 · FY2008 · NS
I-Corps Proposal for Commercialization of Live Cell Assays to Identify and Interrogate Stressed Neurons in Models of Neurodegenerative Disease$55,000
R43 · FY2019 · NS
A New Modular Tool Set for Live Imaging and Manipulating the Nervous System$36,668
R41 · FY2009 · NS